Hypermarcas (OTCMKTS:HYPMY) Stock Crosses Below 50-Day Moving Average - What's Next?

Key Points

• Hypermarcas stock price has fallen below its 50-day moving average of $4.60, trading at $4.24 with a low of $4.24 during recent trading sessions.
• Scotiabank has upgraded Hypermarcas shares to a "strong-buy" rating, contributing to a consensus rating of "Strong Buy" among analysts.
• The company recently declared a dividend of $0.0345, with a dividend yield of 281.0%, and a payout ratio of 57.14%.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report)'s share price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.60 and traded as low as $4.24. Hypermarcas shares last traded at $4.24, with a volume of 355 shares traded.

Analyst Upgrades and Downgrades

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Strong Buy".

Hypermarcas Stock Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The stock has a 50 day simple moving average of $4.57 and a two-hundred day simple moving average of $4.11. The company has a market cap of $2.58 billion, a PE ratio of 19.43 and a beta of 0.86.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. This represents a yield of 281.0%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's dividend payout ratio is currently 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.